Rohto Pharmaceutical Co.,Ltd. / Fundamentals
Income statement
- Net revenue
€1.71B - Cost of goods sold
€731.96M - Gross profit
€975.47M - SG&A expenses
€510.01M - R&D expenses
€46.48M - EBITDA
€263.17M - D&A
€50.90M - EBIT
€213.10M - Interest expenses
€831.84K - EBT
€229.58M - Tax expenses
€59.31M - Net income
€170.90M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€170.90M - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€356.50M - Cash and short-term investments
€356.50M - Total receivables
€312.34M - Inventory
€353.85M - Other current assets
€164.10M - Total current assets
€1.19B - Property, plant & equipment
€501.55M - Goodwill
€265.83M - Intangible assets
€49.33M - Long-term investments
€277.73M - Other non-current assets
€51.74M - Total non-current assets
€1.15B - Total assets
€2.33B - Accounts payable
€117.13M - Short-term debt
€121.41M - Other current liabilities
€377.66M - Total current liabilities
€616.21M - Long-term debt
€102.76M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€70.61M - Total non-current liabilities
€173.36M - Total liabilities
€789.57M - Common stock
€37.57M - Retained earnings
€1.28B - Other equity
€187.86M - Total equity
€1.54B - Total liabilities and shareholders' equity
€2.33B
Company information
- Market capitalization
€2.65B - Employees
7.3K - Enterprise Value
€442.73B
Company ratios
- Gross margin
-
57.1% Even with peer group: 59.2% - EBITDA margin
-
15.4% Worse than peer group: 22.5% - EBIT margin
-
12.5% Worse than peer group: 19.2% - EBT margin
-
13.4% Worse than peer group: 18.6% - Net margin
-
10.0% Even with peer group: 13.1% - ROE
-
11.1% Even with peer group: 10.7% - ROA
-
7.3% Even with peer group: 8.1% - Asset turnover
-
73.2% Better than peer group: 67.9% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
84.6% - Net sales per employee
-
€235.21K - Net income per employee
-
€23.54K